3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical scrutiny due to limited information suggesting distinct physiological properties. Current analyses suggest that 3-HPC may exhibit independent impacts on the brain nervous system, possibly influencing to some of the unexplained reactions related